Biophysical properties of the clinical-stage antibody landscape

…, EM Krauland, Y Xu, M Vásquez… - Proceedings of the …, 2017 - National Acad Sciences
Antibodies are a highly successful class of biological drugs, with over 50 such molecules
approved for therapeutic use and hundreds more currently in clinical development. …

Design criteria for engineering inorganic material-specific peptides

BR Peelle, EM Krauland, KD Wittrup, AM Belcher - Langmuir, 2005 - ACS Publications
Development of a fundamental understanding of how peptides specifically interact with
inorganic material surfaces is crucial to furthering many applications in the field of …

Peptide-mediated reduction of silver ions on engineered biological scaffolds

KT Nam, YJ Lee, EM Krauland, ST Kottmann… - Acs Nano, 2008 - ACS Publications
Herein we report the spontaneous reduction of silver ions into nanostructures by yeast
surface-displayed glutamic acid (E 6 ) and aspartic acid (D 6 ) peptides. Light spectroscopy and …

Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers

…, JC Geoghegan, M Vásquez, EM Krauland… - Science Translational …, 2023 - science.org
Multiple studies of vaccinated and convalescent cohorts have demonstrated that serum
neutralizing antibody (nAb) titers correlate with protection against coronavirus disease 2019 (…

Probing the interface between biomolecules and inorganic materials using yeast surface display and genetic engineering

BR Peelle, EM Krauland, KD Wittrup, AM Belcher - Acta Biomaterialia, 2005 - Elsevier
Although promising for biomimetic materials applications, polypeptides binding inorganic
material surfaces and the mechanism of their function have been difficult to characterize. This …

Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity

…, ME Brown, L Zhou, M Welin, EM Krauland… - MAbs, 2023 - Taylor & Francis
Bispecific antibodies continue to represent a growth area for antibody therapeutics, with
roughly a third of molecules in clinical development being T-cell engagers that use an anti-CD3 …

Profiling the biophysical developability properties of common IgG1 Fc effector silencing variants

…, AB Cooper, ME Brown, M Vásquez, EM Krauland - Antibodies, 2023 - mdpi.com
Therapeutic antibodies represent the most significant modality in biologics, with around 150
approved drugs on the market. In addition to specific target binding mediated by the variable …

Peptide tags for enhanced cellular and protein adhesion to single‐crystalline sapphire

EM Krauland, BR Peelle, KD Wittrup… - Biotechnology and …, 2007 - Wiley Online Library
In order to facilitate a novel means for coupling proteins to metal oxides, peptides were identified
from a dodecamer peptide yeast surface display library that bound a model metal oxide …

Development of a synthetic population model for assessing excess risk for cardiovascular disease death

MG Krauland, RJ Frankeny, J Lewis, LA Brink… - JAMA network …, 2020 - jamanetwork.com
Importance Evaluating the association of social determinants of health with chronic diseases
at the population level requires access to individual-level factors associated with disease, …

Towards rational design of peptides for selective interaction with inorganic materials

EM Krauland - 2007 - dspace.mit.edu
Utilizing molecular recognition and self-assembly, material-specific biomolecules have shown
great promise for engineering and ordering materials at the nanoscale. These molecules, …